Inventor · disambiguated record
Massimo Loda
Also filed as: LODA MASSIMO
3 granted patents·5 pending applications·46 citations·filing 2000–2017
71Inventor score
Top patents by PatentIndex Score
8 records- 0186US10900086B1Compositions and methods for diagnosing prostate cancer using a gene expression signatureDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 26, 2021·10 cites·16 claims
- 0285US6946256B1Cell regulatory genes, encoded products, and uses related theretoDANA FARBER CANCER INST INC·Filed 2000·Granted Sep 20, 2005·34 cites·24 claims
- 0367US9828643B2Chromosome copy number gain as a biomarker of urothelial carcinoma lethalityROSENBERG JONATHAN E·Filed 2012·Granted Nov 28, 2017·2 cites·16 claims
- 0449US2018135132A1Chromosome copy number gain as a biomarker of urothelial carcinoma lethalityDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 0543US2015330984A1Metabolomic profiling defines oncogenes driving prostate tumorsDANA FARBER CANCER INST INC·Filed 2013·Application pending·0 cites
- 0642US2006019310A1Cell regulatory genes, encoded products, and uses related theretoMCKEON FRANK·Filed 2005·Application pending·0 cites
- 0740US2020088748A1Metabolic profiling of fixed samplesDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 0840US2015310169A1Metabolic profiling in tissue and serum is indicative of tumor differentiation in prostate cancerDANA FARBER CANCER INST INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Massimo Loda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →